GSK PLC 2025 SR
The report outlines GSK's sustainability progress in 2025 across its six responsible business focus areas. Key achievements include supplying 560 million doses of medicines and vaccines to lower-income countries and reducing operational greenhouse gas emissions (Scope 1 and 2) by 45% compared to a 2020 baseline. Additionally, the company achieved its target of transitioning 100% of imported electricity to renewable sources. GSK also progressed seven Global Health pipeline assets to address priority WHO diseases and achieved 100% compliance with wastewater active pharmaceutical ingredient limits across its sites and key suppliers.
Company: GSK PLC
Sector: Health Care
Country: United Kingdom
Year: 2025
Type: SR
Pages: 37
GSK PLC
Responsible Business Report
The report outlines GSK's sustainability progress in 2025 across its six responsible business focus areas. Key achievements include supplying 560 million doses of medicines and vaccines to lower-income countries and reducing operational greenhouse gas emissions (Scope 1 and 2) by 45% compared to a 2020 baseline. Additionally, the company achieved its target of transitioning 100% of imported electricity to renewable sources. GSK also progressed seven Global Health pipeline assets to address priority WHO diseases and achieved 100% compliance with wastewater active pharmaceutical ingredient limits across its sites and key suppliers.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Net Zero Target